Tag #Drug Prices

Showing 1 to 12 of 23 results

zeit.de

🌐 85% Global Worthiness

Sep 17, 19:16

EU Drug Shortages Remain a Critical Risk

The European Court of Auditors reports persistent critical shortages of essential medicines in the EU, reaching record highs in 2023 and 2024, affecting 136 medicines between January 2022 and October 2024, impacting all drug types and posing risks to public health and strategic autonomy.

EU Drug Shortages Remain a Critical Risk

The European Court of Auditors reports persistent critical shortages of essential medicines in the EU, reaching record highs in 2023 and 2024, affecting 136 medicines between January 2022 and October 2024, impacting all drug types and posing risks to public health and strategic autonomy.

Progress

16% Bias Score

ShareSaveArticle

Good Health and Well-being

12345678

Previous 1 of 8 Next

What are the primary causes of these widespread drug shortages?

The report identifies weaknesses in supply chains and a fragmented EU internal market for medicines with restricted trade as the main causes. The EU's complete dependence on Asia for common pain relievers like paracetamol and ibuprofen exacerbates the problem.

cnn.com

🌐 85% Global Worthiness

Aug 19, 01:17

Novo Nordisk Offers $499 Ozempic to US Patients

Novo Nordisk is offering Ozempic for $499 per month to US patients paying out-of-pocket, responding to political pressure to lower drug costs and competition from compounding pharmacies.

Novo Nordisk Offers $499 Ozempic to US Patients

Novo Nordisk is offering Ozempic for $499 per month to US patients paying out-of-pocket, responding to political pressure to lower drug costs and competition from compounding pharmacies.

Progress

40% Bias Score

ShareSaveArticle

Good Health and Well-being

12345678

Previous 1 of 8 Next

What is the impact of Novo Nordisk's discounted Ozempic price on the broader US healthcare landscape?

Novo Nordisk announced a $499 monthly price for Ozempic for cash-paying US patients, bypassing insurance. This follows President Trump's pressure on drugmakers to lower costs and mirrors a similar price reduction for Novo Nordisk's Wegovy.

us.cnn.com

🌐 85% Global Worthiness

Aug 11, 13:16

Trump's Aggressive Push for Lower Drug Prices

President Trump claims a 1500% drug price reduction, while his administration pressures pharmaceutical companies to adopt "Most Favored Nation" pricing, matching US drug prices to those in other developed countries, potentially facing legal challenges and impacting drugmakers' profits and patients' ...

Trump's Aggressive Push for Lower Drug Prices

President Trump claims a 1500% drug price reduction, while his administration pressures pharmaceutical companies to adopt "Most Favored Nation" pricing, matching US drug prices to those in other developed countries, potentially facing legal challenges and impacting drugmakers' profits and patients' ...

Progress

40% Bias Score

ShareSaveArticle

Good Health and Well-being

12345678

Previous 1 of 8 Next

What is the core goal of President Trump's drug pricing initiative, and what immediate impact is anticipated?

President Trump claims to have cut drug prices by 1,500%, a figure experts deem impossible. His main strategy involves pressuring drugmakers to adopt "Most Favored Nation" pricing, matching US drug prices to those in other developed countries. This policy, previously blocked in court, is now being pursued through voluntary compliance or government intervention.

french.china.org.cn

🌐 85% Global Worthiness

Aug 1, 10:13

Trump Demands 60-Day Drug Price Cuts from Pharmaceutical CEOs

President Trump sent letters to 17 pharmaceutical CEOs on July 6th, 2023, demanding a 60-day price reduction for medications or unspecified consequences, citing US drug prices as up to three times higher than in other developed nations and invoking the "most-favored-nation" policy.

Trump Demands 60-Day Drug Price Cuts from Pharmaceutical CEOs

President Trump sent letters to 17 pharmaceutical CEOs on July 6th, 2023, demanding a 60-day price reduction for medications or unspecified consequences, citing US drug prices as up to three times higher than in other developed nations and invoking the "most-favored-nation" policy.

Progress

52% Bias Score

ShareSaveArticle

Good Health and Well-being

12345678

Previous 1 of 8 Next

What are the potential long-term implications of President Trump's actions for drug pricing in the US and the pharmaceutical industry?

This situation highlights the ongoing political pressure on pharmaceutical companies to lower drug prices in the US. The potential consequences of non-compliance remain unclear, but it underscores the significant tension between drug manufacturers and the administration. The long-term outcome will depend on the specific measures employed by the administration and the response of pharmaceutical companies.

lemonde.fr

🌐 85% Global Worthiness

Jun 7, 13:13

Trump Administration Intensifies Pressure on Pharmaceutical Pricing

The Trump administration's intensified pressure on the pharmaceutical industry, including tariffs and price negotiation frameworks, aims to address high US healthcare spending (17.6% of GDP) by potentially aligning US drug prices with lower prices in other developed countries, but faces challenges i...

Trump Administration Intensifies Pressure on Pharmaceutical Pricing

The Trump administration's intensified pressure on the pharmaceutical industry, including tariffs and price negotiation frameworks, aims to address high US healthcare spending (17.6% of GDP) by potentially aligning US drug prices with lower prices in other developed countries, but faces challenges i...

Progress

44% Bias Score

ShareSaveArticle

Good Health and Well-being

12345678

Previous 1 of 8 Next

What are the immediate consequences of the Trump administration's actions on pharmaceutical pricing in the US?

The Trump administration's pressure on the pharmaceutical industry involves tariffs on some drugs and a new framework for price negotiation in the US. This is driven by high US healthcare spending (17.6% of GDP vs. 10.4% in Europe on average), a major issue in US elections.

forbes.com

🌐 85% Global Worthiness

May 14, 04:12

Trump's Executive Order Seeks to Lower U.S. Drug Prices Amidst Global Pricing Imbalance

Donald Trump issued an executive order on Monday aiming to lower U.S. drug prices by 30-80%, following a Sunday Truth Social post; however, the plan faces legal and practical challenges, given the high profit margins and political influence of the pharmaceutical industry and the complex global prici...

Trump's Executive Order Seeks to Lower U.S. Drug Prices Amidst Global Pricing Imbalance

Donald Trump issued an executive order on Monday aiming to lower U.S. drug prices by 30-80%, following a Sunday Truth Social post; however, the plan faces legal and practical challenges, given the high profit margins and political influence of the pharmaceutical industry and the complex global prici...

Progress

48% Bias Score

ShareSaveArticle

Good Health and Well-being

12345678

Previous 1 of 8 Next

What are the immediate impacts and global implications of Trump's executive order on U.S. drug prices?

On Sunday, Donald Trump announced on Truth Social a plan to lower U.S. drug prices by 30-80% "almost immediately," followed by a Monday executive order. A 2024 RAND study showed U.S. drug prices are 278% of those in other OECD countries, with brand-name drugs at 422%.,A2=

bbc.com

🌐 75% Global Worthiness

Sep 1, 16:13

Mounjaro Price Hike Jeopardizes Mental Health Benefits for Weight Loss Patients

Sammi Hill, a 33-year-old mother of two from Nottingham, UK, regained her mental well-being and lost 4st (25.4kg) using Mounjaro, but a significant price increase threatens her continued access and the mental health of others.

Mounjaro Price Hike Jeopardizes Mental Health Benefits for Weight Loss Patients

Sammi Hill, a 33-year-old mother of two from Nottingham, UK, regained her mental well-being and lost 4st (25.4kg) using Mounjaro, but a significant price increase threatens her continued access and the mental health of others.

Progress

40% Bias Score

ShareSaveArticle

Good Health and Well-being

12345678

Previous 1 of 8 Next

What is the primary impact of Mounjaro's price increase on patients like Sammi Hill?

The 170% price hike, though slightly reduced, makes Mounjaro unaffordable for many, jeopardizing their mental health improvements. Sammi, who used Mounjaro to overcome depression and regain confidence, may discontinue use due to the increased cost.

gr.euronews.com

🌐 85% Global Worthiness

Aug 17, 13:18

Global Disparities in Medicine Affordability Revealed

A study analyzing 549 essential medicines across 72 markets reveals that while richer nations pay higher list prices, their purchasing power results in lower effective costs compared to poorer nations, where essential medicines can cost low-income individuals several weeks' wages.

Global Disparities in Medicine Affordability Revealed

A study analyzing 549 essential medicines across 72 markets reveals that while richer nations pay higher list prices, their purchasing power results in lower effective costs compared to poorer nations, where essential medicines can cost low-income individuals several weeks' wages.

Progress

56% Bias Score

ShareSaveArticle

Good Health and Well-being

12345678

Previous 1 of 8 Next

How do government policies and price regulations impact the cost and accessibility of essential medicines across different countries?

The study analyzed 549 essential medicines across 72 global markets, finding that European countries spent the most on these drugs—$2 billion total and $192 per capita—while Southeast Asia spent only $7 per capita. However, list prices are misleading; adjusting for purchasing power reveals that the US pays three times the German price, while Lebanon's prices are one-fifth that of Germany. This illustrates how purchasing power significantly impacts the true cost of essential medications across various nations.

theguardian.com

🌐 85% Global Worthiness

Aug 6, 16:15

Trump's Tariff Threats Plunge European Pharma Stocks

European pharmaceutical stocks plummeted to a three-month low after Donald Trump reiterated his threat to impose tariffs of up to 250% on imported drugs within 18 months, impacting companies like Bayer and Novo Nordisk and prompting investment in US drug manufacturing.

Trump's Tariff Threats Plunge European Pharma Stocks

European pharmaceutical stocks plummeted to a three-month low after Donald Trump reiterated his threat to impose tariffs of up to 250% on imported drugs within 18 months, impacting companies like Bayer and Novo Nordisk and prompting investment in US drug manufacturing.

Progress

56% Bias Score

ShareSaveArticle

Good Health and Well-being

12345678

Previous 1 of 8 Next

What is the immediate impact of Trump's renewed tariff threats on European pharmaceutical companies?

Trump's renewed threat to impose steep tariffs on pharmaceutical imports has sent European pharmaceutical stocks to a three-month low. The STOXX Healthcare index dropped 1.6% on Wednesday, reaching its lowest point since mid-April, following Trump's announcement of tariffs reaching 250% within a year and a half. This directly impacts European pharmaceutical companies' profitability and market valuation.

forbes.com

🌐 85% Global Worthiness

Jul 27, 19:15

Trump's Healthcare Policies Threaten Access for Millions

President Trump's healthcare policies, including Medicaid cuts, ACA subsidy rollbacks, and pharmaceutical tariffs, threaten to eliminate health insurance for over 10 million Americans, increase out-of-pocket costs drastically, and severely compromise the affordability and accessibility of healthcare...

Trump's Healthcare Policies Threaten Access for Millions

President Trump's healthcare policies, including Medicaid cuts, ACA subsidy rollbacks, and pharmaceutical tariffs, threaten to eliminate health insurance for over 10 million Americans, increase out-of-pocket costs drastically, and severely compromise the affordability and accessibility of healthcare...

Progress

64% Bias Score

ShareSaveArticle

Good Health and Well-being

12345678

Previous 1 of 8 Next

What are the immediate consequences of the "One Big Beautiful Bill" and the potential expiration of ACA subsidies on healthcare access for American citizens?

One Big Beautiful Bill" will eliminate health insurance coverage for over 10 million Americans within the next decade, disproportionately affecting vulnerable populations like children, the elderly, and the disabled. This loss of coverage will lead to delayed or forgone medical care, resulting in poorer health outcomes and increased financial burdens.

elpais.com

🌐 75% Global Worthiness

May 17, 04:07

Petro Resubmits Popular Consultation, Adding Question on Medicine Prices

President Gustavo Petro of Colombia will resubmit a popular consultation proposal including a new question on lowering medicine prices, following the Senate's rejection of the initial proposal focusing on labor law changes, amidst ongoing medicine shortages and public protests.

Petro Resubmits Popular Consultation, Adding Question on Medicine Prices

President Gustavo Petro of Colombia will resubmit a popular consultation proposal including a new question on lowering medicine prices, following the Senate's rejection of the initial proposal focusing on labor law changes, amidst ongoing medicine shortages and public protests.

Progress

44% Bias Score

ShareSaveArticle

Good Health and Well-being

12345678

Previous 1 of 8 Next

What is the immediate impact of President Petro's decision to resubmit the popular consultation proposal with a focus on medicine prices?

President Gustavo Petro of Colombia will resubmit a proposal for a popular consultation on labor law changes, adding a question about lowering medicine prices. The initial proposal, rejected by the Senate, included questions on night shifts, overtime pay, and disability quotas. The new question directly addresses the current scarcity of medicines in Colombia.

welt.de

🌐 85% Global Worthiness

May 14, 16:10

Trump Decrees US Drug Price Cuts, Proposes Medicaid Cuts

US President Donald Trump issued a decree on Monday mandating that pharmaceutical companies lower drug prices in the US to match the lowest prices in other countries within 30 days, potentially resulting in 59 percent cost reductions, while simultaneously proposing significant Medicaid cuts that cou...

Trump Decrees US Drug Price Cuts, Proposes Medicaid Cuts

US President Donald Trump issued a decree on Monday mandating that pharmaceutical companies lower drug prices in the US to match the lowest prices in other countries within 30 days, potentially resulting in 59 percent cost reductions, while simultaneously proposing significant Medicaid cuts that cou...

Progress

48% Bias Score

ShareSaveArticle

Good Health and Well-being

12345678

Previous 1 of 8 Next

What are the immediate consequences of President Trump's decree on pharmaceutical pricing in the US?

US President Donald Trump signed a decree aiming to significantly lower prescription drug prices in the US by tying them to the lowest prices in other countries. He claims this could result in cost reductions of up to 90 percent in some cases, citing unfair pricing practices by pharmaceutical companies that allegedly charge exorbitant prices in the US to offset discounts in other markets.

Showing 1 to 12 of 23 results